Nano Nuclear Energy Inc.
NNENano Nuclear Energy is an American company focused on the development of nuclear microreactor technologies and related nuclear services, headquartered in New York City and Oak Ridge, Tennessee. The company is an official member of the United States Nuclear Industry Council (USNIC) and the Nuclear Institute based in the United Kingdom. It was selected as a founding member of the HALEU (High Assay Low Enriched Uranium) consortium of the United States Department of Energy.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How NNE's past catalysts played out
No drugs found in this phase.
Frequently asked questions
When is Nano Nuclear Energy Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Nano Nuclear Energy Inc. (NNE) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NNE biotech catalysts?→
Add NNE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Nano Nuclear Energy Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.